Drug intelligence / Profile preview

Selmevit

Development stage
Phase 4
Lead developer
Tyumen State Medical Academy
Modality
Small Molecules
Administration
Oral
01

Overview

Selmevit is a multivitamin and mineral complex with antioxidant properties, containing a combination of vitamins (A, E, C, and B-group) and minerals, including selenium. In clinical research conducted by Tyumen State Medical Academy, Selmevit is being evaluated as an adjunct therapy for women with polycystic ovarian syndrome (PCOS), hyperandrogenism, and menstrual irregularities who are using combined oral contraceptives (COCs). The rationale for its use is that the antioxidant components of Selmevit can limit lipid peroxidation (lipoperoxidation) in platelets, thereby potentially mitigating the hypercoagulation and increased thrombosis risk associated with hormonal contraceptive use. The complex aims to improve hemocoagulation parameters and provide better menstrual cycle control while reducing oxidative stress in this patient population.

Brand names
Selmevit
Other names
Selmevit antioxidant complex
02

Targets

ROS (Reactive oxygen species and organic peroxides)GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on Selmevit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selmevit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call